JP2021527137A5 - - Google Patents
Info
- Publication number
- JP2021527137A5 JP2021527137A5 JP2021518994A JP2021518994A JP2021527137A5 JP 2021527137 A5 JP2021527137 A5 JP 2021527137A5 JP 2021518994 A JP2021518994 A JP 2021518994A JP 2021518994 A JP2021518994 A JP 2021518994A JP 2021527137 A5 JP2021527137 A5 JP 2021527137A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- rpn11
- nhme
- sme
- ome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684265P | 2018-06-13 | 2018-06-13 | |
| US62/684,265 | 2018-06-13 | ||
| US201962835953P | 2019-04-18 | 2019-04-18 | |
| US62/835,953 | 2019-04-18 | ||
| PCT/EP2019/065481 WO2019238817A1 (en) | 2018-06-13 | 2019-06-13 | Bifunctional molecules for targeting rpn11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527137A JP2021527137A (ja) | 2021-10-11 |
| JP2021527137A5 true JP2021527137A5 (cg-RX-API-DMAC10.html) | 2022-06-21 |
Family
ID=67105990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518994A Pending JP2021527137A (ja) | 2018-06-13 | 2019-06-13 | Rpn11を標的化するための二機能性分子 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11925690B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3807272A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2021527137A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20210021016A (cg-RX-API-DMAC10.html) |
| CN (1) | CN112533918A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3103185A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2019238817A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL303717A (en) | 2020-12-18 | 2023-08-01 | Amphista Therapeutics Ltd | Novel bifunctional molecules for targeted protein degradation |
| AU2022362494A1 (en) * | 2021-10-14 | 2024-05-23 | Cullgen (Shanghai), Inc. | Modified proteins and protein degraders |
| CN114959036A (zh) * | 2022-06-07 | 2022-08-30 | 北京大学 | Rpn11标记物在检测骨髓瘤及其患病风险、预后分析及治疗药物中的应用 |
| JP2025525347A (ja) | 2022-06-16 | 2025-08-05 | アンフィスタ セラピューティクス リミテッド | 標的タンパク質分解のための新規の二官能性分子 |
| WO2023242598A1 (en) | 2022-06-16 | 2023-12-21 | Amphista Therapeutics Limited | Bifunctional molecules for targeted protein degradation |
| AU2023343029A1 (en) | 2022-09-13 | 2025-03-27 | Amphista Therapeutics Limited | Compounds for targeted protein degradation |
| AU2023358062A1 (en) | 2022-10-07 | 2025-03-20 | Pfizer Inc. | Hsd17b13 inhibitors and/or degraders |
| WO2024127297A1 (en) | 2022-12-16 | 2024-06-20 | Pfizer Inc. | 3-fluoro-4-hydroxybenzmide-containing inhibitors and/or degraders and uses thereof |
| AU2024395784A1 (en) | 2023-12-07 | 2026-06-11 | Pfizer Inc. | Biphenyl and phenylpyridine compounds as inhibitors of kat2a and/or kat2b |
| GB202319256D0 (en) | 2023-12-15 | 2024-01-31 | Amphista Therapeutics Ltd | Novel compounds for targeted protein degradation |
| WO2026088071A1 (en) | 2024-10-23 | 2026-04-30 | Pfizer Inc. | Substituted fused heteroaryl lactam compounds |
| WO2026154417A1 (en) | 2025-01-17 | 2026-07-23 | Pfizer Inc. | Fused heterocyclic amide/sulfonamide compounds as agonists of the calcitonin/amylin receptors for the treatment of obesity |
| WO2026159633A1 (en) | 2025-01-24 | 2026-07-30 | Pfizer Inc. | 4-(2-(dimethylamino)-2-oxoethyl)-3-methyl-5-oxo-2,3,4,5-tetrahydrobenzofuro[2,3-f][1,4]oxazepine-3-carboxamide compounds and uses thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| WO1993020094A1 (en) | 1992-03-27 | 1993-10-14 | Abbott Laboratories | Haptens, tracers, immunogens and antibodies for quinoline |
| US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| CA2366932C (en) | 1999-04-15 | 2009-08-25 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| US7208157B2 (en) | 2000-09-08 | 2007-04-24 | California Institute Of Technology | Proteolysis targeting chimeric pharmaceutical |
| AU2001295041A1 (en) * | 2000-09-08 | 2002-03-22 | California Institute Of Technology | Proteolysis targeting chimeric pharmaceutical |
| ZA200800314B (en) | 2005-06-29 | 2009-09-30 | Threshold Pharmaceuticals Inc | Phosphoramidate alkylator prodrugs |
| US8552048B2 (en) | 2006-12-26 | 2013-10-08 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs for the treatment of cancer |
| WO2009041072A1 (ja) * | 2007-09-27 | 2009-04-02 | Kowa Company, Ltd. | テトラヒドロキノリン化合物を有効成分とする貧血の予防及び/又は治療剤 |
| GB0913775D0 (en) | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
| EP2649099A4 (en) | 2010-12-07 | 2016-10-19 | Univ Yale | SMALL MOLECULAR HYDROPHOBIC LABELING OF FUSION PROTEINS AND INDUCED REMOVAL FROM THIS |
| EP2710119A4 (en) | 2011-05-17 | 2015-02-18 | Cleave Biosciences Inc | COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION |
| KR102438072B1 (ko) | 2012-01-12 | 2022-08-31 | 예일 유니버시티 | E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법 |
| EP2994135B1 (en) | 2013-05-08 | 2021-10-06 | The Johns Hopkins University | Novel bis-benzylidine piperidinone proteasome inhibitor with anticancer activity |
| EP4649963A3 (en) | 2014-04-14 | 2026-05-13 | Arvinas Operations, Inc. | Imide-based modulators of proteolysis and associated methods of use |
| US9694084B2 (en) | 2014-12-23 | 2017-07-04 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| GB201504314D0 (en) * | 2015-03-13 | 2015-04-29 | Univ Dundee | Small molecules |
| CA2988414C (en) * | 2015-06-04 | 2023-09-26 | Arvinas, Inc. | Imide-based modulators of proteolysis and associated methods of use |
| JP6954619B2 (ja) | 2015-06-19 | 2021-10-27 | 学校法人東京理科大学 | タンパク質分解誘導タグ及びその用途 |
| WO2017024317A2 (en) | 2015-08-06 | 2017-02-09 | Dana-Farber Cancer Institute, Inc. | Methods to induce targeted protein degradation through bifunctional molecules |
| CA2994969A1 (en) | 2015-08-06 | 2017-02-09 | Dana-Farber Cancer Institute, Inc. | Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses |
| US10005735B2 (en) | 2015-08-17 | 2018-06-26 | California Institute Of Technology | Inhibitors of RPN11 |
| GB201516243D0 (en) * | 2015-09-14 | 2015-10-28 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2017253560B2 (en) * | 2016-04-20 | 2019-03-21 | Glaxosmithkline Intellectual Property Development Limited | Conjugates comprising RIPK2 inhibitors |
| CN110035775A (zh) | 2016-11-15 | 2019-07-19 | 学校法人东京理科大学 | Ras蛋白分解诱导分子和药物组合物 |
| CN112236172A (zh) | 2018-01-30 | 2021-01-15 | 福宏治疗公司 | 用于治疗病症的方法和化合物 |
| US11702402B2 (en) | 2018-02-23 | 2023-07-18 | Dana-Farber Cancer Institute, Inc. | Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereof |
| JP7472026B2 (ja) | 2018-02-23 | 2024-04-22 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | 選択的なタンパク質分解を誘導するための低分子およびその使用法 |
| CA3095912A1 (en) | 2018-04-13 | 2019-10-17 | Arvinas Operations, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| EP3677693A1 (en) | 2019-01-03 | 2020-07-08 | Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO | Transpochimeric gene trancripts (tcgts) as cancer biomarkers |
| WO2020146561A1 (en) | 2019-01-09 | 2020-07-16 | Dana-Farber Cancer Institute, Inc. | Dot1l degraders and uses thereof |
-
2019
- 2019-06-13 CA CA3103185A patent/CA3103185A1/en active Pending
- 2019-06-13 US US17/251,615 patent/US11925690B2/en active Active
- 2019-06-13 EP EP19733978.1A patent/EP3807272A1/en not_active Withdrawn
- 2019-06-13 JP JP2021518994A patent/JP2021527137A/ja active Pending
- 2019-06-13 KR KR1020217000928A patent/KR20210021016A/ko not_active Withdrawn
- 2019-06-13 WO PCT/EP2019/065481 patent/WO2019238817A1/en not_active Ceased
- 2019-06-13 CN CN201980039241.8A patent/CN112533918A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533181A5 (cg-RX-API-DMAC10.html) | ||
| JP7449864B2 (ja) | エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用 | |
| CN101657454B (zh) | 18f-标记的叶酸类 | |
| JP2011518194A5 (cg-RX-API-DMAC10.html) | ||
| JP2022537773A5 (cg-RX-API-DMAC10.html) | ||
| Jacobson et al. | A rapid and simple one-step F-18 labeling of peptides | |
| US11401376B2 (en) | Chemical compounds for coating of nanostructures | |
| RS56171B1 (sr) | Derivati stirilpiridina i njihova upotreba za vezivanje i imidžing amiloidnih plakova | |
| RS55855B1 (sr) | Derivati piridina i pirazina za tretman hronične opstruktivne bolesti pluća | |
| Gai et al. | Synthesis and evaluation of new bifunctional chelators with phosphonic acid arms for gallium-68 based PET imaging in melanoma | |
| KR20160074683A (ko) | 18f-표지된 폴레이트 | |
| JP2007511494A5 (cg-RX-API-DMAC10.html) | ||
| CN102802672B (zh) | 髓鞘碱性蛋白的成像 | |
| US20230348378A1 (en) | Small molecule albumin binders | |
| CN117836013A (zh) | 结合至成纤维细胞活化蛋白(fap)的放射性示踪剂和治疗剂 | |
| JP2014501714A (ja) | コンジュゲートおよび分子イメージングにおけるそれらの用途 | |
| JP5693950B2 (ja) | 18f標識葉酸 | |
| US20040053911A1 (en) | Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them | |
| AU2014205481A1 (en) | Therapeutic indications of kinase inhibitors | |
| CN102558091B (zh) | 一种苯并噻唑类衍生物及其用途 | |
| Basuli et al. | A first synthesis of 18F‐radiolabeled lapatinib: a potential tracer for positron emission tomographic imaging of ErbB1/ErbB2 tyrosine kinase activity | |
| KR100186799B1 (ko) | 단백질에 금속 이온을 부착하기 위한 킬레이트제 | |
| Wang et al. | Rational design of pyridinium styryl derivatives as PET tracers for cardiac amyloidosis imaging | |
| Kimura et al. | Radiosynthesis of novel pitavastatin derivative ([18F] PTV‐F1) as a tracer for hepatic OATP using a one‐pot synthetic procedure | |
| Kogler et al. | Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging |